CTRI/2018/10/015937进行中（未招募）未知
The efficacy of intracoronary Nicorandil prior to stenting in prevention of no-reflow/ slow-reflow phenomenon during primary angioplasty
Dr Sreejith A G0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients undergoing primary PCI
排除标准
- •patients with cardiogenic shock; severe liver, renal, or brain dysfunction; or other serious complications at the time of admission were excluded. Those who had taken nicorandil prior to admission w also excluded
研究者
相似试验
招募中
3 期
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1IRCT20230110057096N1Rasht University of Medical Sciences264
招募中
不适用
effect of eptifibatide and reteplase on primary angioplasty outcomesAcute Myocardial Infarction.Acute myocardial infarctionIRCT20170925036401N2Deputy of Research of Guilan University of Medical Sciences160
招募中
不适用
effect of eptifibatide and reteplase on primary angioplasty outcomesAcute myocardial infarctionAcute Myocardial Infarction.IRCT20170925036401N1Rasht University of Medical Sciences160
Unknown
4 期
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial InfarctionCoronary Heart DiseaseNCT02435797Xuzhou Central Hospital100
招募中
4 期
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery DiseaseNo-Reflow PhenomenonPercutaneous Coronary InterventionCoronary Artery DiseaseNCT05427786Korea University Anam Hospital458